Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas Rappl is active.

Publication


Featured researches published by Thomas Rappl.


Annals of Plastic Surgery | 2003

Treatment of painful neuroma by resection and nerve stump transplantation into a vein.

Horst Koch; Franz Haas; Martin Hubmer; Thomas Rappl; Erwin Scharnagl

Twenty-three patients (14 men, 9 women) with 24 painful neuromas underwent resection of neuroma and transposition of the nerve stump into an adjacent vein. The neuromas resulted from amputations (N = 7), tumor excision (N = 5), laceration injuries (N = 4), different types of wrist surgery (N = 3), vein-stripping procedures (N = 2), open fracture of the radius (N = 1), and toe harvest for thumb reconstruction (N = 1). The duration of painful symptoms averaged 66.7 weeks at the time of operation. Average follow-up was 26.5 months. In 22 patients the symptoms improved permanently. Twelve patients experienced complete and permanent relief of pain; some mild degree of pain returned in 8 patients. Two patients experienced moderate pain, and pain recurred unchanged 2 months postoperatively in 1 patient. The results presented are consistent with results of animal experiments demonstrating that typical neuroma does not develop in nerve stumps transposed into veins. Further clinical use of this approach is encouraged.


Clinical, Cosmetic and Investigational Dermatology | 2013

Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study

Thomas Rappl; Daryousch Parvizi; Herwig Friedl; Maria Wiedner; Simone May; Bettina Kranzelbinder; Paul Wurzer; Bengt Hellbom

Background Three botulinum neurotoxin type A preparations (incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA) are widely approved in Europe and in the US for the treatment of glabellar frown lines. The purpose of this study was to determine and compare the time to onset and duration of treatment effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA for the treatment of glabellar frown lines. Subjects and methods Subjects aged 20–60 years with moderate to severe glabellar frown lines received one treatment of either 21 units (U) incobotulinumtoxinA, 21 U onabotulinumtoxinA, or 63 U abobotulinumtoxinA. Assessments were made over a period of 180 days. Onset of treatment effect was defined as the day that the observer noted a decrease in glabellar muscle activity compared with baseline photographs and videos. Duration of treatment effect was defined as the time until glabellar muscle action returned to the baseline level. Analyses were performed using a Weibull log(T) regression model. Results The study enrolled 180 subjects; 60 per group. For all three products, onset of treatment effect occurred earlier in female subjects compared to male subjects. For both sexes, a significantly earlier time to onset of treatment effect was seen for incobotulinumtoxinA compared to onabotulinumtoxinA and abobotulinumtoxinA; in female subjects these times were 3.02 days, 5.29 days, and 5.32 days, respectively. The duration of treatment effect was longer for incobotulinumtoxinA compared to onabotulinumtoxinA and abobotulinumtoxinA; for all products, treatment effect duration was longer in females than in males. Time to onset was not a predictor of treatment duration. Conclusion IncobotulinumtoxinA demonstrated a more rapid onset and a longer duration of treatment effect than onabotulinumtoxinA (1:1 dose ratio) and abobotulinumtoxinA (1:3 dose ratio). Onset of effect was faster and duration of effect was longer in female subjects compared to male subjects.


Wound Repair and Regeneration | 2017

Evidence of invasive and non-invasive treatment modalities for hypertrophic scars: A systematic review

Mona Kafka; Vanessa N. Collins; Lars Peter Kamolz; Thomas Rappl; Ludwik K. Branski; Paul Wurzer

Currently, there are various therapeutic approaches to reduce hypertrophic scarring; however, there is no standard evidence‐based treatment protocol. Hence, a systematic review was performed to obtain a summary of the latest clinical trials to evaluate evidence for the treatment of hypertrophic scars. The review protocol was registered and approved by PROSPERO (CRD42015027040). PubMed and Web of Science were searched using predefined MeSH‐Terms to identify studies published within the last 10 years regarding treatment for hypertrophic scars. Exclusion criteria included a level of evidence (LoE) lower than I, nonhuman in vivo studies, in vitro studies, studies on keloids, literature reviews, and non‐English articles. The literature search identified 1,029 unique articles, whereas 6 articles were prospective, randomized, blinded, controlled clinical trials with a LoE I, and were thus included in the systematic analysis. Three clinical trials evaluated silicone products and pressure garments, and the other three studies investigated the efficacy of intralesional injections of triamcinolone (TAC), 5‐Fluorouracil (5‐FU) combined with TAC as well as the additional irradiation with a 585 nm pulsed‐dye laser (PDL). Intralesional injections revealed significant improvements of the scar quality in terms of height, thickness, erythema, and pigmentation. Pressure garments showed favorable results but there was no evidence that silicone products were able to improve the scar quality. The systematic review demonstrated that there are just a few clinical trials with a LoE of I. Consequently, evidence is still lacking especially for noninvasive treatment regimens for hypertrophic scars. Intralesional injections of 5‐FU mixed with a low dose of TAC can be seen as most appropriate treatment modality. Prospective clinical trials to determine the efficiency of silicone products are warranted.


Breast Journal | 2014

First Experience Using Contrast‐enhanced Ultrasound to Evaluate Vascularisation of Acellular Dermal Matrices after Implant‐Based Breast Reconstruction

Daryousch Parvizi; Franz M. Haas; Florentia Peintinger; Martin Hubmer; Thomas Rappl; Horst Koch; Michael V. Schintler; Stephan Spendel; Lars-Peter Kamolz; Paul Wurzer; Alexandru Tuca; Michael Fuchsjaeger; Roland Weinke

Acellular dermal matrices (ADM) have been used frequently in therapeutic and prophylactic breast procedures. To date there have been no reports on vascularisation of ADMs and formation of tissue around them as seen with modern non‐invasive imaging techniques such as contrast‐enhanced ultrasound (CEUS). In this case series, we used CEUS to investigate the features of ADM in relation to vascular ingrowth and scaffold for “new” tissue formation. This is a retrospective evaluation of patients who underwent successful skin‐ and nipple‐sparing mastectomy (SSM, NSM) with immediate IBBR using ADM from May 31, 2010, through December 28, 2012. Over a 24‐month period, 16 patients, with an average age of 44 years (range 27–70 years), were evaluated with CEUS. No contrast agent allergies or side effects were reported for the ultrasound examination. After contrast agent injection (1–18 months postoperatively), homogeneous normal enhancement in the ADM and peripheral region with physiological tissue formation was seen in all patients. In this small study, the most obvious contribution of CEUS is the in vivo evaluation of vascular ingrowth and tissue formation after IBBR with ADM after follow‐up of 1–18 months postoperatively.


Transplant International | 2015

Effectiveness of porcine dermal collagen in giant hernia closure in patients with deleterious fascia constitution after orthotopic liver transplantation

Georg Werkgartner; Herwig Cerwenka; Thomas Rappl; Daniela Kniepeiss; Peter Kornprat; F. Iberer; Heinz Bacher; Mathias Wagner; Hans Joerg Mischinger; Doris Wagner

Incisional hernias (IHs) occur universally after orthotopic liver transplantation (OLT). This study aimed to investigate the effectiveness of porcine dermal collagen (PDC) as a closing aid in giant hernias after OLT in a prospective trial. If direct closure (DC) was not feasible due to the hernia size and abdominal wall constitution, a PDC mesh was implanted. All patients from the PDC and DC groups were followed prospectively for 24 months. IH recurrence rates served as the primary endpoint, and the development of infections and wound healing disorders served as the secondary endpoints. Recurrence rate was 21% (4/19) in DC patients and 12% (2/16) in PDC patients (P = 0.045). Implant site infections occurred in five of PDC and one of DC patients (P < 0.05). All of them were managed with antibiotics; two of the PDC patients required surgical drainage. Histological analysis of PDC mesh biopsies indicated good angiogenesis and integration of the PDC into the abdominal wall. PDC was effective in our study for incisional hernia repair, and our results compared favourably with those of patients in whom direct hernia closure was feasible.


Burns | 2015

Aesthetically and functionally satisfying reconstruction of an Achilles tendon and overlying skin defect in a 15 year old girl: A case report

Paul Wurzer; Robert Eberl; Lars-Peter Kamolz; Daryousch Parvizi; Thomas Rappl; Stephan Spendel

Achilles tendon and overlying soft tissue reconstruction presents an interdisciplinary challenge. In the literature many possible procedures are described, but each reconstruction in this region has its specific demands. Single stage reconstruction is normally pursued, but it is not always the best procedure for the patient, either aesthetically or functionally. We present a case of a 15 year old girl who suffered a soft tissue defect of 10cm×6cm in size at the area of the Achilles tendon due to a contact burn by an exhaust pipe during a motorcycle accident. For this case, reconstruction of the soft tissue defect using a free temporoparietal fascial flap (TPFF) and a full-thickness skin autograft was the best means to provide a satisfying result for both the patient and the surgeon.


Microsurgery | 2003

Free osteocutaneous lateral arm flap: anatomy and clinical applications.

Franz Haas; Thomas Rappl; Horst Koch; Petra Pittler; Erwin Scharnagl


Lasers in Surgery and Medicine | 2002

Treatment of spider leg veins with the KTP (532 nm) laser—A prospective study

Stephan Spendel; Eva-Christina Prandl; Michael V. Schintler; Alexander Siegl; Gabriela Wittgruber; Bengt Hellbom; Thomas Rappl; Andrea Berghold; Erwin Scharnagl


Burns | 2015

Smartphone applications in burns

Paul Wurzer; Daryousch Parvizi; David B. Lumenta; Michael Giretzlehner; Ludwik K. Branski; Celeste C. Finnerty; David N. Herndon; Alexandru Tuca; Thomas Rappl; Christian Smolle; Lars Peter Kamolz


Obesity Surgery | 2015

A Multiple Regression Analysis of Postoperative Complications After Body-Contouring Surgery: a Retrospective Analysis of 205 Patients

Daryousch Parvizi; Herwig Friedl; Paul Wurzer; Lp. Kamolz; Patricia Lebo; Alexandru Tuca; Thomas Rappl; M. Wiedner; K. Kuess; Martin Grohmann; H. Koch

Collaboration


Dive into the Thomas Rappl's collaboration.

Top Co-Authors

Avatar

Daryousch Parvizi

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Paul Wurzer

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Stephan Spendel

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Herwig Friedl

Graz University of Technology

View shared research outputs
Top Co-Authors

Avatar

Horst Koch

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Alexandru Tuca

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin Hubmer

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Erwin Scharnagl

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Lars-Peter Kamolz

Medical University of Graz

View shared research outputs
Researchain Logo
Decentralizing Knowledge